SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-21-001690
Filing Date
2021-07-27
Accepted
2021-07-26 19:22:01
Documents
1
Period of Report
2021-07-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 19724
  Complete submission text file 0001640334-21-001690.txt   20916
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 211115506
SIC: 2834 Pharmaceutical Preparations